(Q57218350)

English

The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients

article

In more languages

Statements

scholarly article

0 references

The VAD chemotherapy regimen plus a G-CSF dose of 10 μg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 μg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients (English)

0 references

1 reference

based on heuristic

inferred from title

Olivier Hermine

object named as

O Hermine

7

0 references

Marina Cavazzana

14

object named as

M Cavazzana-Calvo

0 references

author name string

F Lefrère

1

0 references

S Zohar

2

0 references

D Ghez

3

0 references

R Delarue

4

0 references

F Audat

5

0 references

F Suarez

6

0 references

G Damaj

8

0 references

N Maillard

9

0 references

J A Ribeil

10

0 references

M Azagury

11

0 references

R Misbahi

12

0 references

K Jondeau

13

0 references

L Dal Cortivo

15

0 references

B Varet

16

0 references

language of work or name

0 references

publication date

6 March 2006

0 references

Bone Marrow Transplantation

0 references

37

0 references

8

0 references

725-729

0 references

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705308

0 references

Single versus double autologous stem-cell transplantation for multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

21 January 2018

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

21 January 2018

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

21 January 2018

A simplified approach to stem cell mobilization in multiple myeloma patients not previously treated with alkylating agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

21 January 2018

Comparison of peripheral blood progenitor cell mobilization in patients with multiple myeloma: high-dose cyclophosphamide plus GM-CSF vs G-CSF alone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

21 January 2018

Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

21 January 2018

Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors affecting both peripheral blood progenitor cell mobilization and hematopoietic recovery following autologous blood progenitor cell transplantation in multiple myeloma patients: a monocentric study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood stem cell collection using chemotherapy with or without systematic G-CSF: experience in 52 patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential value of vintristine-adriamycin-dexamethasone combination chemotherapy (VAD) in refractory and rapidly progressive myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised study comparing peripheral blood progenitor mobilisation using intermediate-dose cyclophosphamide plus lenograstim with lenograstim alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705308

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1705308

0 references

Dimensions Publication ID

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57218350&oldid=1977607162"